MICROVI BIOTECH, INC.
Hayward, US · Founded 2008 · 19 employees on LinkedIn
Find your way into MICROVI BIOTECH, INC.
102 people in our graph share verified history with the MICROVI BIOTECH, INC. team — schools, employers, funds. One of them is your warm intro.
Microvi is a biotechnology company that develops MicroNiche Engineering (MNE) biocatalyst systems for water and wastewater treatment, including nitrogen, nitrate, phosphorus, and hexavalent chromium removal, as well as industrial bioprocessing applications. It serves municipal water utilities and industrial customers across the United States and United Kingdom.
Founders & leadership
Board
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2014
▶$5MraisedNov 2014 · 1 investors · BiotechnologyRule 506(b)
- Ali DorriExecutive Officer
- Dr. Dirk BrusisDirector
- C. Robert KidderDirector
- Fatemeh ShiraziExecutive Officer, Director
- Hamid Rabie, Ph.DDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 19 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $174.6K |
| Department of Agriculture (USDA) | Phase I | 2019 | $100K |
| Environmental Protection Agency (EPA) | Phase II | 2017 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2016 | $225K |
| Department of Energy | Phase I | 2016 | $150K |
| Environmental Protection Agency (EPA) | Phase I | 2016 | $100K |
| Department of Agriculture (USDA) | Phase I | 2016 | $100K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2014 | $1.5M |
| National Science Foundation | Phase I | 2014 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $150K |
| Department of Agriculture (USDA) | Phase I | 2013 | $100K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $131K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2007 | $598.1K |
| National Science Foundation | Phase II | 2005 | $500K |
| National Science Foundation | Phase I | 2003 | $99.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2002 | $275.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does MICROVI BIOTECH, INC. do?
- Microvi is a biotechnology company that develops MicroNiche Engineering (MNE) biocatalyst systems for water and wastewater treatment, including nitrogen, nitrate, phosphorus, and hexavalent chromium removal, as well as industrial bioprocessing applications. It serves municipal water utilities and industrial customers across the United States and United Kingdom.
- How much funding has MICROVI BIOTECH, INC. raised?
- MICROVI BIOTECH, INC. has disclosed $5M raised across 1 round.
- Where is MICROVI BIOTECH, INC. headquartered?
- MICROVI BIOTECH, INC. is headquartered in Hayward, US.